Back to News
Market Impact: 0.55

JPMorgan lowers Palomar stock price target to $158 on slower earthquake growth

JPMPLMRPIPR
Corporate EarningsAnalyst EstimatesAnalyst InsightsCompany FundamentalsCorporate Guidance & OutlookMarket Technicals & FlowsInvestor Sentiment & Positioning
JPMorgan lowers Palomar stock price target to $158 on slower earthquake growth

Palomar Holdings (PLMR) reported strong Q2 2025 results, exceeding revenue and EPS estimates, yet the stock declined over 8% last week, prompting multiple analyst price target reductions despite maintained positive ratings. JPMorgan, for example, lowered its target to $158 (from $170) while keeping an Overweight rating, attributing the stock's underperformance to market reaction over slower earthquake insurance growth. The firm believes PLMR's current valuation of $120.38 is undervalued given its potential from other segments and likely above-peer long-term growth trajectory, highlighting a divergence between immediate market sentiment and analyst long-term outlook.

Analysis

Palomar Holdings (PLMR) presents a clear divergence between strong reported fundamentals and negative market sentiment. The company surpassed Q2 2025 analyst expectations with an EPS of $1.76 against a $1.67 estimate and revenues of $496.3 million, which were 8.1% above projections. Despite this, the stock declined 8.5% over the past week and fell over 15% immediately post-announcement, driven by management's guidance of slower growth in its core earthquake insurance segment. This has triggered a series of price target reductions from analysts at JPMorgan, Piper Sandler, and Keefe, Bruyette & Woods, who cited the earthquake segment slowdown, a higher-than-expected expense ratio, and 'unusual seasonality' as respective concerns. However, these firms uniformly maintained their positive ratings ('Overweight' or 'Outperform'), signaling a belief in the long-term thesis. JPMorgan's commentary is particularly salient, arguing that the market has overreacted and that growth in casualty and crop insurance can sustain the company's earnings trajectory. They assert that Palomar's current valuation, trading below specialty insurance peers on 2027 earnings multiples, does not adequately price in its long-term, above-peer growth potential.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.